Diabetes

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Renee Rucinsky, DVM, DABVP, discussed insulin therapy and SGLT2 inhibitors in her lecture at the Fetch dvm360 conference in Atlantic City

Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ, explains how Sodium-Glucose Cotransporter 2 Inhibitors are used to manage diabetes mellitus in cats

Each article highlights different advancements in the world of veterinary diabetes treatment and management

Education materials and starter kits to help clients manage diabetes in their pets are accessible through the Diabetes PetCare Alliance

Alex Sigmund, DVM, DACVO, discusses health issues that topical steroids and an antiglaucoma therapy can cause, ahead of his lecture at Fetch Kansas City

Dechra Limited has purchased Akston Biosciences’ developmental therapies for cats and dogs with diabetes

How new medications on the market are improving the lives of cats and pet owners.

Therapeutic success can be maximized through dietary modifications

A new peer-reviewed paper published in BMC Veterinary Research shows the potential veterinary use of weight loss drug implant

Trupanion analyzed over 20 years’ worth of data to identify common concerns for cats

Nationwide reveals the most common reason pets sought out veterinary care in 2023

An overview of this life-threatening condition will help guide veterinary practitioners

The program is expected to discuss a new oral hypoglycaemic agent (SGLT2-inhibitor) for management of feline diabetes

The Akston Biosciences technology is used to design therapies for humans and animals with diabetes

A recent study investigates therapeutic strategies for dogs with the disease that may also benefit humans with diabetes

We have compiled a countdown of our top 15 articles in 2023, here is number 15

Check out this week’s headlines

A novel class of drugs normalizes blood glucose in type 2 diabetic cats by dumping sugar into urine rather than modulating glucose uptake in the tissues but patient selection and close monitoring are crucial to using them safely

A discussion on the traditional treatments for feline diabetes, with an introduction to some newer options coming to the market

Fetch Coastal lecturer Liza Wysong, BAS, RVT, VTS (CP-CF, SAIM), describes the discrepancies of this disease in dog and cat patients and the importance of an individualized approach

Akston Biosciences Corporation is working to development drugs to treat diabetes in pets as well as chronic pain in dogs and canine cancers

SENVELGO is a once daily medication to improve glycemic control in cats with diabetes mellitus

In this interview, faculty member Dr Natalie Marks previews this must-attend session that will take place at the Fetch Charlotte Conference

Improves in-clinic and at-home diabetes monitoring for more informed decisions surrounding patient care

We have compiled a countdown of our top 20 articles in 2022, here is number 14

Understanding the diagnostic dilemmas associated with feline hyperthyroidism and how to resolve these with additional testing

The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.

The earlier pets are diagnosed with diabetes, the greater odds of living long, healthy lives

Heather Kvitko-White, DVM, DACVIM, shared her thoughts on using continuous glucose monitors with diabetic patients.